Epic Deterioration Index May Identify High- and Low-Risk COVID-19 Patients
The Epic Deterioration Index (EDI) can identify subsets of high- and low-risk patients with coronavirus disease 2019 (COVID-19).
The Epic Deterioration Index (EDI) can identify subsets of high- and low-risk patients with coronavirus disease 2019 (COVID-19).
Researchers are exploring the potential immunomodulatory and anti-inflammatory effects of UC-MSC infusions for ARDS in COVID-19.
College campuses are at risk for developing extreme incidence of COVID-19, which can spread beyond their campus.
Physician assistants and nurse practitioners share their COVID-19 vaccination experiences.
The Abbott BinaxNOW COVID-19 Ag Card (BinaxNOW) rapid antigen test has lower sensitivity than RT-PCR for detecting SARS-CoV-2 infection,.
This month’s Legal Advisor column looks at the Family Medical Leave Act (FMLA) as it relates to COVID-19.
Recommendations from the American College of Cardiology/American Heart Association Task Force on the management of blood cholesterol.
In the 8 weeks following the first reported UK death due to COVID-19, there was a decrease in referral of patients with acute heart failure.
The sensitivity of reflectance confocal microscopy is evaluated in the context of basal cell carcinoma diagnosis.
More than half of children treated with MRI-guided laser interstitial thermal therapy (MRgLITT) achieve seizure freedom at 1-year follow-up.